Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elizabeth Mittendorf"'
Autor:
Elizabeth Mittendorf, Jennifer Guerriero, Anita Mehta, Geoffrey Shapiro, Madeline Townsend, Madisson Oliwa, Patrice Lee, Nicholas Saccomano, Filipa Lynce
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f105ccb4d7e6416090f569bc5399d79a
Autor:
Elizabeth Mittendorf, Jennifer Guerriero, Peter Sorger, Nadine Tung, Anita Mehta, Emily Cheney, Christina Hartl, Constantia Pantelidou, Madison Oliwa, Jessica Castrillon, Jia-Ren Lin, Mateus de Oliveira Taveira, Nathan Johnson, William Oldham, Marian Kalocsay, Matthew Berberich, Sarah Boswell, Aditi Kothari, Shawn Johnson, Deborah Dillon, Mikel Lipschitz, Scott Rodig, Sandro Santagata, Judy Garber, José Yélamos, Geoffrey Shapiro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bf791cf00da94f9eac81dac39c1b962d
Autor:
Jonathan S Goldberg, Xiaoyong Cui, Kenichi Shimada, Sandra McAllister, Sara Tolaney, Adrienne Waks, Rinath Jeselsohn, Jennifer Guerriero, Judith Agudo, Elizabeth Mittendorf
Publikováno v:
Cancer Research. 82:P1-04
Background: Tumor infiltrating lymphocytes (TILs) are observed in low numbers in HR+ breast cancer relative to other subtypes. For T cells (TC) to recognize and respond to a tumor, antigens must be presented on the tumor cell surface via human leukoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c206144ba9dfd0f21e0b781f4a6e485
https://doi.org/10.1158/1538-7445.sabcs21-p1-04-13
https://doi.org/10.1158/1538-7445.sabcs21-p1-04-13
Autor:
Tess A. O'Meara, Tanya E. Keenan, Adrienne G. Waks, Kristen D. Felt, Bijaya Sharma, Scott Rodig, Melissa Hughes, Nancy U. Lin, Judith Agudo, Jennifer L. Guerriero, Sandra S. McAllister, Elizabeth Mittendorf, Sara Tolaney
Publikováno v:
Cancer Research. 82:P1-04
Background: Although immune checkpoint inhibitors (ICI) are most widely used in PD-L1 positive, metastatic triple-negative breast cancer (TNBC), the clinical utility of ICI in other tumor subtypes and patient populations is not well defined. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1980cc76b143de2c0bee3d07e0ec9baa
https://doi.org/10.1158/1538-7445.sabcs21-p1-04-05
https://doi.org/10.1158/1538-7445.sabcs21-p1-04-05
Autor:
Esther R Ogayo, Adrienne Waks, Wade Rogers, Matei Ionita, Kenechukwu Adigwe, Jillian Alberti, Sapana Kadel, Jonni Moore, Tari King, Ian Krop, Sara Tolaney, Eric Winer, Jennifer Guerriero, Elizabeth Mittendorf
Publikováno v:
Cancer Research. 82:P5-13
Background: DAPHNe was a prospective trial designed to assess adherence to de-escalated antibody doublet therapy in the adjuvant setting among HER2+ breast cancer patients experiencing a pathologic complete response (pCR) following neoadjuvant taxol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5174dab700fba2a1d2bbddee3001b491
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-15
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-15
Autor:
Gordon B. Mills, Ana Maria Gonzalez-Angulo, William F. Symmans, Savitri Krishnamurthy, Rosa Hwang, Isabelle Bedrosian, Gildy Babiera, Elizabeth Mittendorf, Zerzhinski M. Garces, Kim-Anh Do, Gopal Singh, Beatriz E. Adrada, Selin Carkaci, Emily Tarco, Aysegul Sahin, Huiqin Chen, Argun Akcakanat, Funda Meric-Bernstam
Background: PI3K/Akt/mTOR signaling is being actively pursued as a therapeutic target for breast cancer. We sought to determine if tumor heterogeneity and biospecimen variables affect the evaluation of PI3K/Akt/mTOR pathway markers.Methods: Intraoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193a8d6a5b952a336785297be279f819
https://doi.org/10.1158/1078-0432.c.6520658
https://doi.org/10.1158/1078-0432.c.6520658
Autor:
Gordon B. Mills, Ana Maria Gonzalez-Angulo, William F. Symmans, Savitri Krishnamurthy, Rosa Hwang, Isabelle Bedrosian, Gildy Babiera, Elizabeth Mittendorf, Zerzhinski M. Garces, Kim-Anh Do, Gopal Singh, Beatriz E. Adrada, Selin Carkaci, Emily Tarco, Aysegul Sahin, Huiqin Chen, Argun Akcakanat, Funda Meric-Bernstam
Supplementary Table 5: The tumor cellularity of each biospecimen as assessed by H&E Supplementary Table 6: Correlation of protein expression by RPPA between different biospecimens (Spearman's correlation). Analysis was conducted in samples with ï‚
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a927cb5fed1e2a941d4e88cc6348959
https://doi.org/10.1158/1078-0432.22446140
https://doi.org/10.1158/1078-0432.22446140
Autor:
Milos Spasic, Adrienne Parsons, Gregory Goreczny, Qiuchen Guo, John Hutchinson, Elizabeth Mittendorf, Peter van Galen, Sandra McAllister
Publikováno v:
Cancer Research. 83:623-623
Understanding how aging impacts cancer progression is critical to improving therapeutic responses. As we age our risk of developing most forms of cancer increases. Conversely, our immune function declines, and though over half of breast cancer patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50c4d56375cab4c415803f21fb701e6d
https://doi.org/10.1158/1538-7445.am2023-623
https://doi.org/10.1158/1538-7445.am2023-623
Autor:
Paolo Tarantino, Romualdo Barroso-Sousa, Ana C. Garrido-Castro, Sandra S. McAllister, Jennifer L. Guerriero, Elizabeth Mittendorf, Giuseppe Curigliano, Sara M. Tolaney
Publikováno v:
Expert review of anticancer therapy. 22(2)
The addition of immune checkpoint inhibitors (ICIs) to frontline chemotherapy has improved survival for patients with advanced triple-negative breast cancer (TNBC) expressing programmed death-ligand 1 (PD-L1). Nonetheless, most patients develop resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21be43513b4287e0c2ec031e4c6fa70f
https://pubmed.ncbi.nlm.nih.gov/34919490
https://pubmed.ncbi.nlm.nih.gov/34919490
Autor:
Tyler Hether, Tim Howes, David Scoville, Charlie Glaser, Yanyun Li, Rami Vanguri, Neeman Mohibullah, Wan-Jung Chang, Todd Yoder, Minnal Gupta, Kathy Ton, Yan Liang, Ying Huang, Zach Herbert, Jason Reeves, Elizabeth Mittendorf, Simon Lacey, Travis Hollmann, Sarah Warren, Theresa LaVallee
Publikováno v:
Cancer Research. 82:66-66
Multiplexed spatial profiling can enable biological insights by characterizing gene expression within discrete physical locations of a tissue. However, these advanced techniques can be confounded by variability of sample collection, storage, or profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a13f16f227e2fcfa880061c66d6874ce
https://doi.org/10.1158/1538-7445.am2022-66
https://doi.org/10.1158/1538-7445.am2022-66